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Abstract. Intraperitoneal administration of lipoic acid (10 mg/100 g) does not effect changes 
in serum insulin levels in normal and alloxan diabetic rats, while normalising increased serum 
pyruvate, and impaired liver pyruvic dehydrogenase characteristic of the diabetic state. 
Dihydrolipoic acid has been shown to participate in activation of fatty acids with equal facility 
as coenzyme A. Fatty acyl dihydrolipoic acid however is sparsely thiolyzed to yield acetyl 
dihydrolipoic acid. Also acetyl dihydrolipoic acid does not activate pyruvate carboxylase 
unlike acetyl coenzyme A. The reduced thiolysis of ß-keto fatty acyl dihydrolipoic acid esters 
and the lack of activation of pyruvic carboxylase by acetyl dihydrolipoic acid could account for 
the antiketotic and antigluconeogenic effects of lipoic acid. 
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Introduction 
 
The role of lipoic acid as a cofactor in the multienzyme complexes that catalyze the 
oxidative decarboxylation of α-keto acids such as pyruvate, α-ketoglutarate and 
branched chain α-keto acids has been established for some time (Reed, 1974). Since 
lipoic acid can be biosynthesised in the animal (Spoto et al., 1982; Carreau et al., 1977; 
Carreau, 1979), little attention has been given to a dietary requirement for lipoic acid 
per se or lipoic acid content of dietary constituents, which in any case is relatively low 
(Herbert and Guest, 1975). In an earlier communication (Natraj et al., 1984) we have 
shown that lipoic acid levels are reduced in alloxan diabetic rats and administration of 
lipoic or dihydrolipoic (DTO) acid reduces blood sugar and acetoacetate levels at the 
same time bringing about an increase in liver glycogen and fat synthesis. The mode of 
action of lipoic acid was, however, not considered. 
It is well known that administration of insulin or oral hypoglycemic agents which 
stimulate insulin secretion correct the metabolic disorders in diabetes. Therefore, the 
first thing to look for is whether lipoic acid stimulates insulin secretion and whether the 
antidiabetic effect of lipoic acid is exerted through insulin. In this study we have shown 
that lipoic acid administration does not stimulate insulin secretion in normal and 
diabetic rats ruling out insulin as the mediator of the hypoglycemic effects of lipoic acid 
Another possibility is that, in view of its reduced levels in diabetic rat livers, lipoic 
 
 
Abbreviations used: CoA, Coenzyme A; DTO, dihydrolipoic acid; DTNB, 5, 5' dithiobis (2 nitrobenzoic acid); 
DTT, dithiothreitol; NAD, nicotinamide adenine dinucleotide; PD, Pyruvate dehydrogenase; PC, pyruvate 
carboxylase. 
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acid Substitution in the enzyme complexes, where it is known to be a cofactor, is 
reduced. One such enzyme is pyruvate dehydrogenase (PD) (EC 1.2.4.1) which is a 
crucial enzyme located at the metabolic branch point between carbohydrate, fat and 
protein metabolisms. In this study we have shown that PD activity is stimulated upon 
lipoic acid administration and this is reflected in a reduction in serum pyruvate levels. 
In diabetes, major impairments in carbohydrate, fat and protein metabolisms occur. 
Impaired transport of glucose into tissues and decreased activity of hexokinase (May 
and Mikulecky, 1983) result in reduced utilization of glucose. Much of the energy 
requirements in the liver and kidney are met by fatty acid oxidation, resulting in 
increased ketogenesis in these organs (Randle, 1966). Increased fatty acid oxidation also 
triggers increased gluconeogenesis mainly from lactate, alanine and glutamine leading 
to protein catabolism and elevated blood sugar levels (Ruderman et al., 1976; Utter et 
al., 1964). In this paper, we have shown that DTO brings about a reduction in 
acetoacetate levels in the livers of starved rats perfused with octanoate. We have 
therefore examined the effect of lipoic acid on some of the key steps of fatty acid 
oxidation such as fatty acyl coenzyme A (CoA) synthetase (EC 6.2.1.3) and thiolase 
(EC 2.3.1.9) and found that while fatty acyl DTO is formed readily from fatty acids and 
DTO, the oxidation of fatty acids is slower in view of the fact that acetoacetyl DTO and 
perhaps β-ketoacyl DTO is a poor substrate for thiolase. 
Increased activity of pyruvate carboxylase (EC 6.4.1.1) has been implicated in the 
elevated rates of gluconeogenesis in diabetes (Hers and Hue, 1983; Weinberg and Utter, 
1980). We present evidence that acetyl DTO differs from acetyl CoA in that it does not 
stimulate pyruvate carboxylase (PC) thus accounting for the hypoglycemic effect of 
lipoic acid. 
 
 
Materials and methods 
 
DL α-lipoic acid and alloxan were purchased from British Drug House, England. Radio 
immunoassay kit for insulin assay was procured from Bhabha Atomic Research Centre, 
Bombay. Acetoacetyl CoA, ATP, CoA, bovine serum albumin, diketene, DTNB, DTT, 
lactate dehydrogenase (LDH) (EC 1.1.1.27), NAD, NADPH and sodium pyruvate were 
purchased from Sigma Chemical Co., St. Louis, Missouri, USA. All other reagents were 
of analytical grade. The rats used were an inbred Haffkine Wistar strain maintained on 
Hindustan Lever pellet feed. Diabetes was induced by a single subcutaneous injection 
of alloxan (100 mg/kg) dissolved in acetate buffer (0.1 M, pH 5.4). Rats excreting sugar 
in the urine (2–3 g/dl) were used in this study. Acetoacetyl DTO was prepared according 
to Drummond and Stern (1961). Acetyl DTO was prepared according to Gunsalus et al. 
(1956). 
 
Blood pyruvate and liver pyruvate dehydrogenase activity in normal and diabetic rats 
 
Twelve diabetic rats were distributed into two groups and one group received 
intraperitoneally 0·1 ml saline and the other sodium α-lipoate (10 mg/100 g body wt) as 
a solution in saline. Six normal rats received 0·1 ml saline and served as controls. After 
60 min, the rats were sacrificed and blood was collected in a centrifuge tube. The blood 
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pyruvic acid levels were estimated according to the method described by Varley et al. 
(1976). 
Mitochondrial PD was isolated according to the method of Linn et al. (1972). 
Eighteen normal and 18 diabetic rats were distributed into 3 groups each. One group 
was injected 0·1 ml saline, a second group sodium lipoate (10 mg/100 g body wt) as a 
solution in 0·1 ml saline and the third group received insulin (4 I.U./100g). All 
injections were intraperitoneal. 
Assay of PD was carried out according to the procedure of Stepp et al. (1981). The 
assay mixture contained in a volume of 1 ml, 2·5 µmol of NAD, 0·32 µmol DTT, 
potassium phosphate buffer (pH 8·0, 50 µmol), 2 µmol pyruvate, 1 µmol magnesium 
chloride and 0·13 µmol, CoA or DTO. The reaction was started by adding an aliquot of 
the enzyme (approximately 100 µg protein) and the reduction of NAD monitored at 
340 nm. Protein was estimated according to Lowry et al. (1951). The product of the 
reaction with DTO was identified by extracting the reaction mixture with benzene, 
evaporating the solvent and formation of acetyl hydroxamate according to Lipmann 
and Tuttle (1945). 
 
Serum insulin levels in normal and diabetic rats 
 
Forty normal and 24 diabetic rats were divided into 2 groups and kept away from food 
for 3 h. One group was administered intraperitoneally 0· 1 ml of saline and the other 
sodium α-lipoate (10 mg/100 g) dissolved in 0·1 ml saline. After 60 min the rats were 
sacrificed and the blood was collected in centrifuge tubes. Blood sugar was estimated 
according to the method of Somogyi (1952). Serum insulin was estimated by the 
method of Herbert et al. (1965) as modified and described in the booklet supplied by 
Bhabha Atomic Research Centre, Bombay, along with the radioimmunoassay kit for 
insulin. 
 
Acetoacetate levels in starved rat livers perfused with octanoate 
 
Normal male adult rats weighing about 250 g were starved for 48 h. The rats were 
anaesthetized with ether and canulated through the portal vein. Livers were perfused 
for 60 min with oxygenated Krebs bicarbonate buffer containing either 2 mM 
octanoate or 2 mM octanoate and 2 mM DTO. The perfusion volume was 100 ml. The 
perfusate was collected and to 5 ml of the perfusate 2 ml of chilled trichloroacetic acid 
(TCA; 20 %) was added and centrifuged. Acetoacetate in the supernatant was estimated 
according to the method described by Walker (1954). 
 
 
Activation of fatty acids with DTO catalyzed by acyl Co A synthetase 
 
The enzyme was isolated from normal rat liver microsomes according to the procedure 
of Dang et al. (1984). The crude microsomal pellet was used as the source of the enzyme. 
The assay was performed according to the procedure of Dang et al. (1984) with some 
modifications. The assay mixture in a final volume of 1 ml contained 200 µmol Tris HCl 
buffer, pH 7·5, 4 µmol of MgSO4, 1·25 µmol of CoA/DTO, 0·1 mg Triton X-100 
0·02 µmol of potassium palmitate (containing 30,000 CPM 1-14C palmitate) and 
approximately 100 µg enzyme protein, The reaction was started by adding 10 µmol of 
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ATP and incubating for 3 min. Palmitoyl CoA formed was estimated by extracting the 
acidified reaction mixture with diethyl ether and determining the radioactive counts in 
the aqueous layer. The palmitoyl DTO formed was estimated by extracting the acidified 
reaction mixture with ether and the free palmitic acid was separated from the palmitoyl 
DTO in the ether layer by thin layer chromatography using n-hexane: diethyl ether: 
acetic acid (80:20: 1; v/v) as the solvent system. The band corresponding to palmitoyl 
DTO was cut out and counted. 
The control for the above assay contained all the ingredients except ATP. 
 
Acetoacetyl CoA and acetoacetyl DTO as substrates for thiolase 
 
Thiolase was partially purified from normal rat livers (upto 60 % ammonium sulphate 
fractionation step) according to the procedure of Stern et al. (1960). Each assay mixture 
contained in a final volume of 1 ml: 67 µmol of Tris buffer (pH 8·1) 0·2 µmol acetoacetyl 
thioester, 1·4 mg enzyme and 0·22 µmol of thiol. The reaction was monitored 
spectrophotometrically by the decrease in absorbance at 310 nm. All the components 
with the exception of the acetoacetyl thioester were added to the reference cuvette. 
 
Pyruvate carboxylase and acetyl DTO 
 
PC was isolated from rat liver mitochondria according to the procedure described by 
Scrutton et al. (1969). The assay was carried out by coupling it with citrate synthase 
according to Martin and Denton (1970). 
The assay mixture in a final volume of 1 ml contained: 100 µmol of Tris buffer pH 7·4, 
10 µmol of sodium pyruvate, 10 µmol of MgCl2, 1 µmol of ATP, 0·5 µmol of acetyl 
CoA/acetyl DTO, 30 µmol of sodium bicarbonate, 100 µg of pyruvate carboxylase, 
160 µg of citrate synthase and 1 µmol of DTNB. The increase in absorbance at 412 nm 
was followed spectrophotometrically. 
 
Results 
 
Effect of lipoic acid on blood pyruvate and liver pyruvate dehydrogenase activity in 
normal and diabetic rats 
 
Serum pyruvate levels are increased in diabetes and after lipoic acid administration, the 
levels are brought down to near normal values (table 1). This decrease was statistically 
significant (P < 0·05). 
Liver PD is 2 times higher in normal rats than in diabetic rats (table 2). In 
both normal and diabetic rats, lipoic acid administration brought about significant 
increases in the enzyme activity. The increase was 60 % in normal rats and 90 % in 
diabetic rats. This compares with an increase of 74 % and 111 % observed in normal 
and diabetic rats respectively, following insulin administration. 
The results of substitution of DTO for CoA in the estimation of PD are shown in 
table 3. The activity of the enzyme was approximately 50% of that with CoA. The 
product of the reaction with DTO was identified as acetyl DTO by the hydroxamate 
assay of Lipmann and Tuttle (1945). Thus, DTO can substitute for CoA in the 
decarboxylation of pyruvate catalyzed by PD in the absence of CoA. 
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Table 1. Effect of lipoic acid on serum pyruvate 
levels. 
 
Lipoic acid was administered (10 mg/100 g) intra 
peritoneally and serum pyruvate was estimated 
60 min later as described in Materials and 
methods. All the determinations are means of 6 
animals. 
*Significantly greater than normal Ρ < 0·05 
** Significantly less than diabetic Ρ < 0·05 
 
 
Table 2 PD activity in normal and diabetic rat 
livers. 
 
Lipoic acid or insulin was administered intraperitone- 
ally and the animals were sacrificed 60 min later. PD 
was isolated from the livers as described under 
Materials and methods 
All the determinations are means of 6 animals ± SE 
a Significantly different from normal at Ρ < 0·01 
b Significantly different from diabetic at P < 0·05 
c Significantly different from diabetic at Ρ < 0·01 
 
 
Effect of lipoic acid on blood sugar and serum insulin levels 
 
The blood sugar and serum insulin levels are shown in table 4. The blood sugar levels 
decreased significantly in normal rats following lipoic acid administration (60 min after 
single intraperitoneal injection of 50 µmol/100 g body wt sodium lipoate in 0·1 ml 
saline). Although there was a mean reduction in blood sugar values in diabetic rats; 338 
and 288 mg/ 100 ml in saline and lipoic acid injected rats respectively, the reduction was 
not statistically significant due to large variations in the initial blood sugar levels. 
In an earlier report, we had shown that DTO administration brings about a 
significant reduction in blood sugar levels of diabetic rats (Natraj et al., 1984), under 
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Table 3. Acylation of DTO catalyzed by 
rat liver PD. 
 
The enzyme was assayed as described under 
Materials and methods and the activity was 
expressed as nmol of NAD+ reduced/ 
min/mg protein. The product of the reac- 
tion with DTO was identified by extracting 
with benzene, separating the products on 
thin layer chromatography and estimating 
the acetyl DTO as acetyl hydroxamate 
 
 
 
Table 4. Blood sugar and serum insulin levels in normal and 
diabetic rats. 
 
Rats were administered lipoic acid intraperitoneally and sacrificed 
1 h later and the blood sugar and serum insulin estimated as 
described under Materials and methods. 
Numbers in parentheses denote the number of animals used for the 
determination. 
All values are means ± SE. 
a Significantly less than normal blood sugar Ρ < 0·05. 
b Not significantly different from normal serum insulin. 
c Significantly less than normal serum insulin Ρ < 0·01. 
d  Not significantly different from diabetic serum insulin. 
 
 
conditions where the blood sugar was estimated from the same rat before and after 
DTO administration. In the present study, 24 diabetic rats were distributed into 2 
groups based on their urinary sugar. Lipoic acid was administered to one group and 
saline to the other and at the end of 60 min their blood sugar and serum insulin levels 
were estimated and compared. Since the standard error for blood sugar is large, the 
reduction is not statistically significant. 
The mean serum insulin levels were reduced in diabetic rats as compared to normal 
rats (31·6 and 59·6 µ I.U./ml respectively). The mean serum insulin levels following 
lipoic acid administration was however, not significantly different in normal or diabetic 
rats (52·8 and 29·3 µ I.U./ml respectively). 
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Acetoacetate levels in starved rat livers perfused with octanoate 
 
Perfusion of fatty acids in the isolated rat liver from starved rats is known to stimulate 
acetoacetate synthesis (Burch and Wertheim, 1973). From table 5, it can be seen that 
DTO when perfused along with octanoate brought about a 25% reduction in the 
acetoacetate levels in the perfusate. The extent of β-hydroxy butyrate formed was not 
estimated. 
 
 
Table  5.  Acetoacetate levels in liver perfusate. 
 
Livers from starved normal rats were perfused with octanoate or octanoate and 
DTO as described under Materials and methods for 1 h. Acetoacetate in the 
perfusate was estimated according to Walker's procedure ( Walker, 1954) 
 
 
Activation of fatty acids with DTO 
 
Fatty acyl CoA synthetase from normal rat liver microsomes was used to study the 
activation of fatty acids with CoA and DTO. The 1-14C labelled palmitoyl CoA/DTO 
formed in the assay were separated by extraction/thin layer chromatography and the 
radioactivity counted. From table 6, it can be seen that the activity of the enzyme with 
DTO is comparable to that with CoA. 
 
Table 6. Activation of fatty acids with DTO catalyzed by fatty acyl CoA 
synthetase. 
 
Fatty acyl CoA synthetase was isolated from normal rat liver microsomes 
and assayed as described under Materials and methods. Palmitoyl CoA 
formed was estimated by determining the acid soluble counts at the end of 
the assay. Palmitoyl DTO was estimated by extracting the acidified reaction 
mixture with ether and separating the free palmitate from palmitoyl DTO 
on thin layer chromotography using n hexane:diethyl ether:acetic acid 
(80:20:1; v/v) as the solvent system. The band corresponding to palmitoyl 
DTO was cut out and counted. 
 
Thiolysis of acetoacetyl DTO 
 
The thiolase assay was performed by following the reduction in the absorption of the 
acetoacetate functional group spectrophotometrically at 310 nm. Acetoacetyl DTO 
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was found to undergo thiolysis only slowly (approximately 1/25 of the rate of 
acetoacetyl CoA) in the presence of CoA. In the presence of DTO, the rates of both 
reactions were reduced; mixed thiolysis of acetoacetyl CoA by a factor of 8 while the 
thiolysis of acetoacetyl DTO could not be measured (table 7). 
 
Table  7.  Thiolysis of acetoacetyl DTO. 
 
* Decrease in A310 of 0·01/min/mg protein. 
** Not detectable. 
Thiolase was assayed by the decrease in the 310 nm absorb- 
ance (λ max for ß-keto ester functional group) indicative of 
cleavage of the substrate. 
 
 
Pyruvate carboxylase and acetyl DTO 
 
Oxaloacetate which is the product of the pyruvate carboxylase reaction is measured by 
coupling it to citrate synthase. Acetyl CoA allosterically activates PC and is also a 
substrate for the citrate synthase reaction (Utter et al., 1964). Acetyl DTO is also a 
substrate for citrate synthase (unpublished observation). From table 8 it can be seen 
that in the presence of acetyl DTO, the activity of PC was negligible while with acetyl 
CoA the specific activity was 43·8 nmol of citrate formed/min/mg protein. This 
indicates that acetyl DTO does not activate PC to any significant extent. 
 
 
Table  8.  Effect of acetyl DTO on pyruvate carboxylase. 
 
* nmol of citrate formed/min/mg protein. 
** not detectable. 
PC was isolated from normal rat liver and assayed by coupling with 
excess citrate synthase and the activity was determined by estimating 
the rate of release of free –SH groups using DTNB as described 
under Materials and methods. 
 
Discussion 
 
Any proposal for the mode of action of lipoic acid must explain its effect in reducing 
blood sugar, pyruvate and acetoacetate levels and increasing liver glycogen and fat 
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synthesis in diabetic rats. The most obvious explanation would be through stimulation 
of insulin secretion since insulin is known to bring about these changes. Further, 
sulphhydryl containing compounds have been reported to stimulate insulin secretion in 
vitro (Chiba, 1969; Haugaard and Haugaard, 1970; Lavis and Williams, 1970). Since 
DTO has two sulphhydryl groups, it is probable that it stimulates insulin secretion also. 
However, lipoic acid administration in normal or alloxan diabetic rats did not increase 
serum insulin levels, thus ruling out insulin as the mediator of the antidiabetic effects of 
lipoic acid. 
The activity of pyruvate dehydrogenase is reduced in diabetes (Kerbey et al., 1976). 
The mode of inhibition has been shown to be through phosphorylation of the enzyme. 
Insulin is known to reverse this and thus stimulate the enzyme (Hughes et al., 1980). In 
an earlier study, we had shown that liver lipoic acid levels are reduced in diabetes 
(Natraj et al., 1984). In view of this, it is probable that at least a part of the inhibition of 
PD in diabetes could be due to reduced substitution of lipoic acid in the enzyme 
complex. It is logical therefore, to expect that PD activity would be stimulated by lipoic 
acid administration in diabetic rats. In normal rats however, it is not possible to explain 
the observed stimulation of PD by lipoic acid (table 2). It would therefore appear 
unlikely that the stimulation of PD by lipoic acid in normal or diabetic rats is through 
increased substitution of the cofactor at the enzyme level alone. 
A closer scrutiny of the mode of regulation of PD in diabetes shows that increased 
accumulation of acetyl CoA in diabetes leads to acylation of enzyme bound lipoic acid 
(Wieland et al., 1971). This in turn stimulates the kinase which inhibits PD through 
phosphorylation. CoA has been shown to overcome this inhibition (Cate and Roche, 
1983). We have shown that DTO can substitute for CoA in the assay of PD. The 
product of the reaction after extracting from the reaction mixture has been identified as 
acetyl DTO by separating on thin layer chromatography and estimating by the 
hydroxamate method. We propose that DTO overcomes the inhibition of PD in a 
manner analogous to CoA. It must be mentioned that O'Connor et al. (1982) have 
shown that PD catalyzes the acylation of dihydrolipoamide with acetyl CoA as the acyl 
donor. The formation of enzyme bound acetyl DTO and the transfer of the acetyl 
group to CoA in the reaction pathway of PD have been well established. In this study, 
we have shown that in the absence of CoA, the acetyl group of the enzyme bound acetyl 
DTO is transferred to DTO with the formation of free acetyl DTO; this is the first 
demonstration of such a reaction. 
While the above accounts for the activation of PD and the resulting lowering of 
erum pyruvate levels, an important observation from this as well as the previous study 
(Natraj et al., 1984) is the lowering of acetoacetate levels by DTO. It is well known that 
fatty acids predominantly furnish the carbon atoms for acetoacetate synthesis (Ohgaku 
et al., 1983). DTO lowers the acetoacetate levels in the perfusate from starved rats when 
perfused along with octanoate. In order to explain this, we have examined the effect of 
DTO on some of the key steps in fatty acid oxidation. 
The terminal four carbon atoms of an even carbon fatty acid during oxidation can 
give rise to acetoacetyl CoA as can two molecules of acetyl CoA by head to tail 
condensation catalyzed by thiolase (Ohgaku et al., 1983). Acetoacetyl CoA can be 
converted to acetoacetate either through direct deacylation or through the HMG CoA 
pathway (Segal and Menon, 1961; Sauer and Erfle, 1966) giving rise to ketone bodies. 
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Fatty acid oxidation starts with the activation of a fatty acid as its CoA thioester. In 
the present study we have shown that in this reaction DTO can replace CoA effectively. 
The activated fatty acids are oxidized in successive steps with the formation of acetyl 
CoA or acetyl DTO at each step through the thiolysis of β-ketoacyl thioester. The 
reduced rates of thiolysis observed with acetoacetyl DTO as compared to acetoacetyl 
CoA would indicate that during fatty acid oxidation in the presence of DTO thiolysis is 
considerably decelerated thus exerting a braking effect on the overall rate of fatty acid 
oxidation. Further, the head to tail condensation of two acetyl DTO molecules through 
reversal of thiolase reaction is also slower. These two factors would explain the 
observed reduction in ketosis following lipoic acid administration. 
Increased fatty acid oxidation has also been shown to trigger gluconeogenesis from 
lactate and alanine in diabetic animals; "the control of pyruvate carboxylation being 
physiologically the most meaningful interaction between fatty acid oxidation and 
gluconeogenesis" (Williamson et al., 1969). This has been attributed to the elevation in 
intramitochondrial acetyl CoA which activates pyruvate carboxylase (Hers and Hue, 
1983; McClure and Lardy, 1971). The deceleratory effect of DTO on fatty acid 
oxidation would also contribute to a reduction in acetyl CoA levels. We have examined 
the possibility whether acetyl DTO that may be formed from acetyl CoA, would also 
activate PC in a manner analogous to acetyl CoA. The data presented in table 8 show 
that acetyl DTO does not stimulate PC, thus contributing to a reduction in 
gluconeogenesis. 
While lipoic acid or DTO can substitute for CoA in all the reactions examined such as 
formation of acetyl DTO from pyruvate catalyzed by PD, and fatty acyl DTO from 
fatty acids catalyzed by fatty acyl CoA synthetase, two important differences were 
observed: (i) the DTO thioester is a very poor substrate for thiolase. In this connection, 
it must be pointed out that a similar observation has been reported earlier (Drummond 
and Stern, 1957; Stern and Drummond, 1961); (ii) activation of PC by acetyl DTO was 
negligible when compared to acetyl CoA. The observation that activation of fatty acids 
as the DTO thioester proceeds facilely while oxidation of fatty acyl DTO would be 
expected to be slower, leads one to speculate whether DTO has a dominant or accessory 
role in fat biosynthesis. 
In conclusion we propose that the mode of action of lipoic acid in diabetes is through 
preferential slowing down of fatty acid oxidation, and gluconeogenesis (since acetyl 
DTO unlike acetyl CoA does not activate PC) and by overcoming the inhibition of PD 
by acetyl CoA. 
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